Law Professor: Trump Administration Can Still Impose Tariffs Through Other Statutes
The Trump Team Got a Serious Briefing on the 2026 Midterms This Week....
The Trans Ice Rink Shooter Story Just Took a Wild Turn
DC Water CEO: 'We Had Too Many White Men in Charge'
Here's the One Word That Describes US Women's Hockey at the Winter Olympics...
Supreme Court Orders CNN to Respond
The Supreme Court Just Issued Their Ruling on President Trump's Tariffs
California Judge Orders Children's Hospital to Continue 'Gender-Affirming Surgeries' for M...
Susan Rice's Terrifying Vow If Democrats Take Back Power
To the Democrats' Dismay, the List of Hospitals Ending 'Gender-Affirming Surgeries' for Mi...
Democrats Go Blue in Profane Anti-Trump Illinois Senate Campaign Ad
The Democrats Just Picked the Worst Person to Give Their Response to the...
Wisconsin's Republican Assembly Speaker Robin Vos Will Not Seek Reelection
Calling the SAVE Act 'Jim Crow' Is an Insult to History
Republican Steve Hilton Surges to the Lead in California Gubernatorial Race
Tipsheet

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’
AP Photo/Pablo Martinez Monsivais, File

Speaking during remarks to a J.P. Morgan healthcare conference this week, Pfizer CEO Albert Bourla openly stated current vaccines the company developed for Wuhan coronavirus offer "limited, if any" protection against contracting current variants of the disease. He then encouraged booster shots. 

The statement from Bourla comes as the Biden administration continues to justify vaccine mandates for federal workers, contractors and private businesses. The Supreme Court heard arguments about President Biden's mandates for private companies and medical workers last week. A ruling is expected soon on the constitutionality of the mandates. 

A number of people who have pointed out the waning efficacy of Pfizer's vaccines, which Bourla touted last year as being "100 percent" effective against contracting or transmitting the virus, have been banned by social media companies. 

Meanwhile, Bourla also announced this week the company is developing a vaccine specific to Omicron. It is expected to be ready in March when health officials predict the latest wave of the mild variant will already be over. 

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos